Lauren B. Loeffel

Lauren B. Loeffel

Auto-generated profile, based on publicly available information

Lauren B. Loeffel

Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States; National Center for PTSD at VA Boston Healthcare System, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YXYouping Xiao
Youping Xiao
CKChristopher Kavanau
Christopher Kavanau
LBLauren Bertin
Lauren Bertin
EKEhud Kaplan
Ehud Kaplan
Many studies have provided evidence for the existence of universal constraints on color categorization or naming in various languages, but the biological basis of these constraints is unknown. A recent study of the pattern of color categorization across numerous languages has suggested that these patterns tend to avoid straddling a region in color space at or near the border between the English composite categories of “warm” and “cool”. This fault line in color space represents a fundamental constraint on color naming. Here we report that the two-way categorization along the fault line is correlated with the sign of the L- versus M-cone contrast of a stimulus color. Moreover, we found that the sign of the L-M cone contrast also accounted for the two-way clustering of the spatially distributed neural responses in small regions of the macaque primary visual cortex, visualized with optical imaging. These small regions correspond to the hue maps, where our previous study found a spatially organized representation of stimulus hue. Altogether, these results establish a direct link between a universal constraint on color naming and the cone-specific information that is represented in the primate early visual system.

1 December 2018 in Addictive Behaviors
Verified
Journal Article
Closed access
SMSylvie Messer
Sylvie Messer
ASAtara Siegel
Atara Siegel
LBLauren Bertin
Lauren Bertin
JEJoel Erblich
Joel Erblich

1 January 2018 in Addictive Behaviors
Verified
Journal Article
Closed access
LBLauren Bertin
Lauren Bertin
SLSamara Lipsky
Samara Lipsky
JEJoel Erblich
Joel Erblich

27 March 2026 in Translational Psychiatry
Verified
Journal Article
Open access
SHSpencer B. Huggett
Spencer B. Huggett
SSSharmila Selveraj
Sharmila Selveraj
JMJohn E. McGeary
John E. McGeary
AIAmi S. Ikeda
Ami S. Ikeda
EYEmerald Yuan
Emerald Yuan
RPRohan HC Palmer
Rohan HC Palmer
This study explores the neurobiological underpinnings of alcohol use disorder (AUD) by integrating bulk and single-cell transcriptomic data from humans, primates, and mice across three brain regions associated with addiction (i.e., prefrontal cortex (PFC), nucleus accumbens (NAc), and central amygdala (CeA)). We compared AUD RNA expression and cell-type abundance from 92 human brain to data from 53 primates and 90 mice engaged in diverse alcohol use paradigms. The findings revealed significant and reproducible correlations between human AUD and mammalian models of alcohol use that vary by tissue, species, and behavioral paradigm. The strongest correlations occurred between primate and mouse models of binge drinking (i.e., high drinking in the dark). Certain primate models demonstrated that the brain RNA correlations with human alcohol use disorder (AUD) were approximately 40% as strong as the correlations observed within human samples themselves. By integrating single-cell transcriptomic data, this study observed decreased oligodendrocyte proportions in the PFC and NAc of human AUD with similar trends in animal models. Gene co-expression network analyses revealed conserved systems associated with human AUD and animal models of heavy/binge alcohol consumption. Gene co-expression networks were enriched for pathways related to inflammation, myelination, and synaptic plasticity and the genes within them accounted for ~20% of the heritability in human alcohol consumption. Identified hub genes were associated with relevant traits (e.g., impulsivity, motivation) in humans and mice. This study sheds light on conserved biological entities underlying AUD and chronic alcohol use, providing insights into the cellular, genetic, and molecular basis across species.

23 June 2025 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
AMAmar D Mandavia
Amar D Mandavia
JFJennifer R. Fonda
Jennifer R. Fonda
Anne N BanducciAnne N Banducci
Anne N Banducci
VAVictoria E. Ameral
Victoria E. Ameral
RHRebecca E. Sistad Hall
Rebecca E. Sistad Hall
NLNicholas Livingston
Nicholas Livingston

1 May 2025 in Journal of Psychopathology and Clinical Science
Verified
Journal Article
Closed access
NLNicholas Livingston
Nicholas Livingston
AMAmar D. Mandavia
Amar D. Mandavia
ABAnne N. Banducci
Anne N. Banducci
RHRebecca Sistad Hall
Rebecca Sistad Hall
LLLauren B. Loeffel
Lauren B. Loeffel
FMFrank Meng
Frank Meng
Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP methods to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research. (PsycInfo Database Record (c) 2025 APA, all rights reserved).